ArticleOncoTargets and therapy2016

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis.

Zhe-Ling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.